NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0600
0.00 (0.00%)
At close: Jun 18, 2026
NKGen Biotech Employees
NKGen Biotech had 26 employees as of December 31, 2024. The number of employees decreased by 37 or -58.73% compared to the previous year.
Employees
26
Change (1Y)
-37
Growth (1Y)
-58.73%
Revenue / Employee
n/a
Profits / Employee
-$905,923
Market Cap
7.84M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 26 | -37 | -58.73% |
| Dec 31, 2023 | 63 | - | - |
NKGen Biotech News
- 4 weeks ago - NKGen Biotech Expands Clinical Trial Site Network for Alzheimer's Disease Program Across U.S. to Improve Patient Access and Support Enrollment - GlobeNewsWire
- 2 months ago - NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer's and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit - GlobeNewsWire
- 3 months ago - NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer's Disease at AD/PD 2026™ - GlobeNewsWire
- 3 months ago - NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer's Disease at AD/PD™ 2026 - GlobeNewsWire
- 5 months ago - NKGen Biotech appoints Bruce Miller to Scientific Advisory Board - TheFly
- 5 months ago - NKGen Biotech Names Leading Dementia Expert Bruce L. Miller, M.D. - GlobeNewsWire
- 7 months ago - NKGen Biotech issues statement on NKGen Korea board appointments - TheFly
- 9 months ago - NKGen Biotech provides clarification on quotation display, trading status - TheFly